Australia markets closed

    -178.80 (-2.33%)
  • ASX 200

    -166.60 (-2.27%)

    -0.0049 (-0.68%)
  • OIL

    -0.81 (-0.95%)
  • GOLD

    -10.80 (-0.59%)

    -6,469.13 (-10.83%)
  • CMC Crypto 200

    +652.80 (+269.00%)

    -0.0064 (-1.00%)

    -0.0009 (-0.09%)
  • NZX 50

    -149.10 (-1.19%)

    -408.06 (-2.75%)
  • FTSE

    -90.88 (-1.20%)
  • Dow Jones

    -450.02 (-1.30%)
  • DAX

    -308.45 (-1.94%)
  • Hang Seng

    +13.20 (+0.05%)
  • NIKKEI 225

    -250.67 (-0.90%)

Global Defibrillators Market Report 2021: Market will be $18.01 Billion by 2027 from $12.87 Billion in 2021, Growing at a CAGR of 5.76%

·4-min read

Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Defibrillators Market Size, Share, Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been added to's offering.

Global Defibrillators Market will be $18.01 Billion by 2027 from $12.87 Billion in 2021, growing at a CAGR of 5.76% during 2021-2027

Worldwide, different types of defibrillators work in different ways. Say for instance, (AEDs) automated external defibrillators can be seen in many public places to rescue the lives of people who have sudden cardiac arrest. Even untrained people or bystanders can use these devices in an emergency.

Defibrillators are immensely useful in reviving sudden cardiac arrest; this further pushed for the demand for defibrillators in the pandemic situation. Most probably, its timely supportive regulation and rising demand for adoption will see lucrative growth in this market in upcoming years.

The driving force towards global Defibrillators market growth are, awareness about the importance of good cardiac health, surging technology advancement across the globe, cases of cardiac disorders, and legislative reforms. Nevertheless, lack in advanced healthcare infrastructure, high cost, the weak reimbursement policies hinder the growth of the defibrillators market worldwide.

COVID-19 Impact on Medical Defibrillators Market

COVID-19 can affect the cardiovascular system, resulting in myocardial injury, arrhythmias, intravascular thrombosis, and sudden cardiac death. Initial reports have recommended a temporary association between COVID-19 activity and cardiac arrests in the community and within in-hospital settings.

Life-threatening arrhythmias have been variably reported among patients hospitalized for COVID-19 infection. Sudden cardiac arrest (SCA) in COVID-19 patients is an alarming concern for clinicians. Defibrillator shock episodes has risen during the higher COVID-19 activity. Read the complete Defibrillators Market performance in COVID-19 times.

American Heart Association on Defibrillators

American Heart Association stated that about 20,000 lives are saved due to defibrillators' availability every year and suggested that Public Access Defibrillators (PADs) must be available in the residential apartments, transportation centers, and public holdings.

By Product type, we have categorized the global defibrillator market into the Implantable Cardioverter Defibrillator and External Defibrillator market. In this the market of External Defibrillator will grow at a great pace during the forecast period. External defibrillators are life-saving devices used to deliver a defibrillating shock to diagnose and restore heart rhythms in an unexpected cardiac arrest. Apart from that, the market of Implantable Cardioverter Defibrillator will also flourish during 2020-2027.

North America has the Lion Share of the Global Defibrillator Market

This report further segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East& Africa based on region. Upon which North America has the lion share of the global defibrillator market.

Likewise, Asia-Pacific countries like China and India have a huge population base and at the same time, these countries offer immense opportunities to the market players and are expected to be the fastest-growing region during the forecast period.

Company Analysis
1. Medtronic Plc
2. Boston Scientific Corporation
3. Philips Healthcare
4. Nihon Kohden Corporation
5. Asahi Kasei Corporation

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges

5. Global Defibrillator Market

6. Market Share
6.1 Product Type
6.2 Implantable Cardioverter Defibrillator
6.3 Transvenous Implantable Cardioverter Defibrillators
6.4 By External Defibrillators
6.5 By End Users
6.6 By Regions

7. Product Type - Global Defibrillator Market
7.1 Implantable Cardioverter Defibrillator
7.2 External Defibrillator

8. Implantable Cardioverter Defibrillator - Global Defibrillator Market
8.1 Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
8.1.1 Single-Chamber Implantable Cardioverter Defibrillators
8.1.2 Dual-Chamber Implantable Cardioverter Defibrillators
8.1.3 Biventricular Implantable Cardioverter Defibrillators /Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
8.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs)
8.3 Others

9. External Defibrillators - Global Defibrillator Market
9.1 Automated External Defibrillators
9.2 Advanced Life Support Defibrillators
9.3 Wearable Cardioverter Defibrillators

10. End Users - Global Defibrillator Market
10.1 Hospital
10.2 Prehospital
10.3 Public Access Market
10.4 Alternate Care Market
10.5 Home Healthcare

11. By Region - Global Defibrillator Market
11.1 North America
11.2 Europe
11.3 Asia Pacific
11.4 Latin America
11.5 Middle East and Africa

12. Company Analysis
12.1 Overview
12.2 Recent Development & Strategies
12.3 Financial Insights

  • Medtronic Plc

  • Boston Scientific Corporation

  • Philips Healthcare

  • Nihon Kohden Corporation

  • Asahi Kasei Corporation

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting